baber/WOPTO huggingface dataset:
Patent WO-2019102465-A9 (WO)
Inventor: ROTSCHILD CARMEL
IPC: H02S10/00
Filed: 2018-11-21
Abstract: L'invention concerne un système de conversion d'énergie comprenant un matériau photoluminescent (PL) destiné à absorber le rayonnement solaire et à émettre un rayonnement PL, un concentrateur solaire destiné à concentrer le rayonnement solaire sur le matériau PL, un matériau photovoltaïque (PV) conçu pour absorber le rayonnement PL, et une chambre destinée à contenir le matériau PL et un fluide caloporteur (HTF), et comprenant en outre le système conçu pour canaliser le HTF de la chambre vers un système de conversion de la chaleur de HTF en énergie. L'invention concerne également un appareil et des procédés associés.
Patent WO-2012161490-A9 (WO)
Title: Epoxy resin compound and radiant heat circuit board using the same
Inventor: PARK JAE MAN
IPC: H05K7/20
Filed: 2012-05-21
Abstract: An epoxy resin composition having an epoxy resin, a curing agent, and inorganic filler as main components is provided. The epoxy resin includes an epoxy resin of Chemical Formula. Accordingly, the thermal conductivity of the epoxy resin composition can be increased because the epoxy resin has a mesogen structure that facilitates crystallizability. In addition, a high radiant heat board can be provided by using the above-mentioned epoxy resin as an insulating material for a printed circuit board.
Patent WO-2006012586-A9 (WO)
Inventor: BACKHED FREDRIK
IPC: A61K35/741
Filed: 2005-07-25
Abstract: L'invention concerne des compositions et des méthodes permettant de moduler l'accumulation de graisse et la perte de poids d'un sujet. Dans certains aspects de cette invention, l'accumulation de graisse (adiposité) et la perte de poids sont modulées par modification de la population de microbiote gastro-intestinal d'un sujet. Dans d'autres aspects de ladite invention, l'accumulation de graisse et la perte de poids sont modulées par modification de la quantité ou de l'activité de la protéine, du facteur adipeux induisant le jeûne, chez le sujet.
Patent WO-2006055294-A9 (WO)
Title: Procedes et appareil de conversion d'energie faisant appel a des materiaux renfermant du deuterium moleculaire et du deuterure d'hydrogene moleculaire
Inventor: HAGELSTEIN PETER L
IPC: G21B1/00
Filed: 2005-11-01
Abstract: L'invention porte sur un procédé et un appareil qui permettent de soumettre un matériau hôte à un traitement pour entraîner la présence de deutérium moléculaire (D2) et/ou de deutérure d'hydrogène moléculaire (HD) à l'intérieur du matériau hôte, et de traiter le matériau hôte pour entraîner la présence de He-4 et/ou He-3. La stimulation du matériau hôte entraîne des réactions et l'on parvient à extraire de l'énergie du matériau hôte.
Patent WO-2006081542-A9 (WO)
Title: Systeme de traitement de l'eau encapsule
Inventor: KENNEDY GREGORY
IPC: B01D69/02
Filed: 2006-01-27
Abstract: L'invention concerne un système de traitement de l'eau comprenant une manivelle encapsulée présentant une cartouche d'osmose inversée et une ou plusieurs cartouches de filtre. La cartouche de filtre comprend une détente à loger dans une fente ménagée dans la tête de la manivelle, aux fins de prise de verrouillage sure. Le système de traitement de l'eau comprend un seul système de surveillance de la conductivité de la sonde permettant de surveiller les performances d'une membrane d'osmose inversée. Le système de traitement de l'eau se présente dans un agencement modulaire dans lequel les têtes des manivelles sont couplées physiquement et fluidiquement ensemble au moyen d'une attache s'interfaçant avec les têtes de manivelles modulaires. Le système de traitement de l'eau peut être réaménagé de manière à comprendre une pompe de perméat. Les cartouches sont également conçues pour conférer un intervalle d'admission annulaire minimal, afin de minimiser les fuites lors du changement des cartouches.
Patent WO-2013177060-A9 (WO)
Title: Procédés et systèmes pour surveiller, diagnostiquer et traiter la maladie pulmonaire obstructive chronique
Inventor: LAM STEPHEN
IPC: C12Q1/68
Filed: 2013-05-20
Abstract: L'invention concerne un nouveau jeu de 98 gènes exprimés dans l'épithélium du tractus respiratoire qui servent de biomarqueurs pour la mesure de l'activité de la maladie pulmonaire obstructive chronique (MPOC). Des procédés de classification du statut (MPOC) d'un sujet sont décrits. Des systèmes de classification, basée sur l'expression, du statut de la maladie MPOC sont décrits. Des procédés de traitement de la MPOC sont également décrits, entre autres choses.
Patent WO-2021168259-A9 (WO)
Title: Preemption and cancellation in sidelink and uplink access
Inventor: RYU JUNG HO
IPC: H04W72/12
Filed: 2021-02-19
Abstract: Aspects relate to obtaining, at a first scheduled entity, a first priority ranking of first uplink (UL) data scheduled for transmission to a scheduling entity and a first data scheduled for transmission to a second scheduled data, as well as a second priority ranking of second data scheduled for transmission to a third and fourth scheduled entity, respectively. The scheduling uses at least a portion of a sidelink resource reserved for sidelink communication for the transmissions. The scheduling of the transmissions using at least the portion of the sidelink resource are based on the first priority ranking and the second priority ranking. Various transmission cancellation and reception preemptions are transmitted from transmitting scheduled entities to other transmitting or receiving scheduled entities, respectively. Such cancellations and preemptions are based on the priority rankings, prediction of data transmission collisions and prediction of interference at receiving entities.
Patent WO-2022055590-A9 (WO)
Inventor: AMADJIKPE ARNAUD
Filed: 2021-06-22
Abstract: Dans un exemple, un appareil radar peut comprendre un processeur configuré pour générer des informations radar sur la base de données radar d'entrée, les données radar d'entrée étant basées sur des signaux radar d'une antenne radar à entrées multiples et sorties multiples (MIMO), le processeur étant configuré pour générer les informations radar par étalonnage d'un défaut d'appariement d'antenne (MM) de l'antenne radar MIMO dans une première dimension d'un domaine d'azimut-élévation selon une pluralité de matrices de couplage inverse (ICM) unidimensionnelles (1D), la pluralité de ICM 1D correspondant à une pluralité de sous-réseaux d'antennes de l'antenne radar MIMO et à une pluralité d'angles dans une seconde dimension du domaine d'azimut-élévation.
Patent WO-2022212364-A9 (WO)
Inventor: FULLER BENJAMIN JOHN
IPC: G06F1/30
Filed: 2022-03-29
Abstract: Techniques are described herein processing asynchronous power transition events while maintaining a persistent memory state. In some embodiments, a system may proxy asynchronous reset events through system logic, which generates an interrupt to invoke a special persistent flush interrupt handler that performs a persistent cache flush prior to invoking a hardware power transition. Additionally or alternatively, the system may include a hardware backup mechanism to ensure all resets and power-transitions requested in hardware reliably complete within a bounded window of time independent of whether the persistent cache flush handler succeeds.
Patent WO-2023141664-A9 (WO)
Inventor: MEHTA SUNIL
Filed: 2023-03-02
Abstract: L'invention concerne un dispositif d'homogénéisation en flux continu et un procédé d'utilisation dudit dispositif permettant la lyse ou la rupture de cellules, de tissus et d'autres matières biologiques, et la création de plus petites particules et émulsions. Ledit dispositif contient une chambre d'homogénéisation dans laquelle le matériel entrant pénètre en continu dans la chambre via un orifice d'entrée et le matériel homogénéisé s'écoule en continu hors de ladite chambre via un orifice de sortie. La chambre d'homogénéisation peut comprendre au moins une roue qui tourne et/ou effectue un mouvement de va-et-vient à l'intérieur de la chambre en présence ou en l'absence d'un milieu améliorant l'homogénéisation. Le milieu améliorant l'homogénéisation peut comprendre des particules rigides. Toutes les surfaces de contact avec le produit peuvent être stériles et jetables. L'intégralité du processus d'homogénéisation peut être exécuté de façon entièrement automatisée ou manuelle par un dispositif de commande qui gère différentes entrées et sorties des composants du système.
Patent DE-102012013735-A9 (DE)
Title: Resektoskop
Inventor: EHLERS ANGELA
IPC: H01R13/627
Filed: 2012-07-12
Abstract: Ein Resektoskop (1) mit einer an diesem verschiebbar gelagerten Elektrodenanordnung (6), die wenigstens eine zur Beaufschlagung mit Hochfrequenz ausgebildete Elektrode (7, 10) aufweist, die mit einem Kontakt (28, 29) an einem proximalen Endbereich (21) der Elektrodenanordnung (6) elektrisch leitend verbunden ist, sowie mit einem am Resektoskop (1) in Verschieberichtung (8) der Elektrodenanordnung (6) verschiebbar gelagerten Haltekörper (12), der mit einer Elektrodenaufnahme (22) zur Befestigung und zur Kontaktierung des Endbereiches (21) der Elektrodenanordnung (6) ausgebildet ist, und mit einem Kabel (26) mit einem Steckerkörper (27), der zur Befestigung und zur Kontaktierung am Haltekörper (12) ausgebildet ist, wobei der Haltekörper (12) zur Befestigung des Steckerkörpers (27) mit einer Einschubbewegung (34) ausgebildet ist, ist dadurch gekennzeichnet, dass an einem der Körper (27) wenigstens ein Rasthaken (42) federnd gelagert ist, der zum Rasteingriff an einem Rastvorsprung (45) am anderen Körper (12) ausgebildet ist und mit diesem eine die beiden Körper (12, 27) aneinander sichernde Rasteinrichtung bildet.
Patent DE-102015102210-A9 (DE)
Title: Antimykotischer polymerisierbarer Knochenzement und ein Verfahren zu seiner Herstellung
Inventor: VOGT SEBASTIAN
IPC: A61P31/10
Filed: 2015-02-16
Abstract: Es wird ein antimykotisch wirksamer Knochenzement basierend auf organischen Polymeren, wie Polymethylmethacrylat, beschrieben. Der Knochenzement umfasst ein Antimykotikum, insbesondere Amphotericin B, das in Gegenwart von Wasser oder wässrigen Medien, wie Köperflüssigkeit, aus dem polymerisierten Knochenzement freigesetzt wird. Entsprechend einer Alternative liegt das Antimykotikum partikulär vor und ist mindestens teilweise mit einem Gemisch aus mindestens einem 1-Methylamino-1-desoxy-zuckeralkohol und mindestens einer Fettsäure umhüllt. Gleichfalls wird ein Verfahren zur Herstellung des Gemisches umfassend ein Antimykotikum, wie Amphotericin B-Partikel, und 1-Methylamino-1-desoxy-zuckeralkohol und mindestens einer Fettsäure vorgeschlagen. Bevorzugt ist das Antimykotikum zumindest teilweise umhüllt von 1-Methylamino-1-desoxy-zuckeralkohol und mindestens einer Fettsäure.
Patent DE-102019118934-A9 (DE)
Title: Partikelvereinzelungsvorrichtung, Beschichtungsanordnung und Verfahren
Inventor: VIELUF MAIK
IPC: C23C14/24
Filed: 2019-07-12
Abstract: Gemäß verschiedenen Ausführungsformen kann eine Partikelvereinzelungsvorrichtung (100) aufweisen: eine Eingangsöffnung und eine Ausgangsöffnung, mehrere Vereinzelungsstufen (104a, 104b), welche eingerichtet sind, von der Eingangsöffnung zu der Ausgangsöffnung geführte Partikel (106) zu vereinzeln, wobei von den mehreren Vereinzelungsstufen (104a, 104b): eine Vereinzelungsstufe (104b) eine Prallfläche (104p) aufweist und eingerichtet ist, die Partikel (106) in Richtung zu einer Prallfläche (104p) hin zu beschleunigen, so dass ein dadurch bewirkter Aufprall der Partikel (106) auf die Prallfläche (104p) diese voneinander trennt; eine zusätzliche Vereinzelungsstufe (104a) eingerichtet ist, Elektronen in die Partikel (106) einzubringen, so dass eine dadurch bewirkte Aufladung der Partikel (106) diese voneinander trennt.
Patent CS-229101-B1 (CS)
Inventor: BRICHACEK JAN RNDR
IPC: C07C201/12
Filed: 1983-01-03
Abstract: Vynález se týká způsobu přípravy
2-brom-2-xri.tro-l,3-propadiolu, který je
konzervační přísadou do výrobků kosmetické
a bytové chemie. Dosavadní postupy výroby
jsou technologický náročné. Tuto výhodu
odstraňuje způsob podle vynálezu
spočívající v tom, že pro bromaci isolované
alkalické soli 2--nitro-l,3-prodandiolu
se používá bezvodé prostředí průmyslová
běžného reakčního rozpouštědla, v
němž se rozpustí již za studená nebo po
zahřátí pouze produkt a bromid se snadno
oddělí v pevném stavu a prakticky čistý
s možností dalšího využiti.
Patent IE-52359-B1 (IE)
Title: Lipid and protein containing material in particulate form and process therefor
IPC: A23J3/00
Filed: 1982-01-19
Abstract: A dry, free-flowing and non-caking material whose lecithin content can be varied over a wide range is prepared by combining an aqueous medium, a lipid phase containing at least 1 wt% lecithin, and a proteinaceous material, such as : a soy concentrate, comprising a porous particulate substance which includes at least 30 wt% of a substantially water insoluble protein, and drying the resulting mixture. The free-flowing and non-caking nature of the particulate product is attributed to the porous and rigid structure of the proteinaceous material which permits the lipid phase to be contained in the interstitial spaces present in each particle.
Patent DK-175141-B1 (DK)
Inventor: STORZ DIETER
IPC: G11B19/28
Filed: 1990-02-16
Granted: 2004-06-14
Abstract: PCT No. PCT/EP89/00590 Sec. 371 Date Feb. 12, 1990 Sec. 102(e) Date Feb. 12, 1990 PCT Filed May 26, 1989 PCT Pub. No. WO89/12932 PCT Pub. Date Dec. 18, 1989.A phase control circuit in which a first phase comparator compares an input frequency with a reference frequency. The output of the first phase comparator is connected to a controlled oscillator through a control stage. A second control stage is also connected to the input of the controlled oscillator which has an output connected to a second phase comparator which receives also the reference frequency at an input. The output of the second phase comparator is connected to an input of the second control stage. The first control stage is separated from the controlled oscillator to compensate the circuit automatically. The second control stage varies its output until the frequency at the controlled oscillator output equals the reference frequency. The second control stage maintains this level subsequent to compensation independent of the output from the second phase comparator, and the first control stage is reconnected to the input terminal of the controlled oscillator.
Patent IE-54091-B1 (IE)
Title: Safety guard for power-take-off shaft
IPC: F16D3/84
Filed: 1983-02-04
Abstract: A guard for a power transmission shaft such as a tractor pto shaft 18,20 comprises a flexible convoluted tubing 24 with end couplings 26 which together totally enclose the rotating parts. The tubing 24 can extend and retract axially to suit a variety of shaft lengths, and can flex transversely to accommodate turning of the tractor/implement combination. A tube 34 journalled on bearings 36, or equivalent bearing means, prevents damage to the tubing 24 by the shaft 18,20.
Patent IE-35116-B1 (IE)
Title: Improved smoking mixture
IPC: A24B15/14
Filed: 1971-03-22
Abstract: 1316172 Treating tobacco IMPERIAL CHEMICAL INDUSTRIES Ltd 19 April 1971 [23 March 1970] 13867/70 Heading A2C A chlorophyll-free smoking mixture comprises tobacco and a carotenoid, the ratio of carotenoid to tobacco being in the range 1:50 to 1:750. In the examples, shredded reconstituted tobacco sheet is sprayed with solutions of #-carotene, acetate or apocarotenal, and shredded tobacco rag sprayed with a solution of #-carotene. Other isoprenoids specified are α-carotene a naturally occuring mixture of α- and #-carotenes, admixtures of α-, #- and γ-carotenes, lycopene, 15,15'-dihydro-carotene, 4,4'-diketo-15,15'-dihydro-carotene, apocarotenoic acid derivatives, bixin and canthanxanthin. The reconstituted tobacco compositions exemplified are formed from ball milled tobacco together with glycerol, sodium carboxymethyl cellulose, magnesium carbonate and calcium carbonate ,and either potassium citrate or bentonite. In one example, the treated reconstituted tobacco is blended with untreated tobacco rag.
[GB1316172A]
Patent IE-58815-B1 (IE)
Title: Peptides containing an aliphatic-aromatic ketone side chain
IPC: C07K7/23
Filed: 1986-02-11
Abstract: GnRH peptide analogs which regulate the secretion of gonadotropins by the pituitary gland and either promote or inhibit the release of steroids by the gonads. Administration of an effective amount of a GnRH antagonist prevents ovulation of female mammalian eggs and/or the release of gonadotropins. Administration of GnRH agonists can be used to regulate fertility in male and female mammals.These and other peptide hormones exhibit improved binding efficiency and biological potency as a result having a residue in a critical, generally central location in the chain which residue contains a mixed alkyl ketone side-chain terminating in an aromatic group. Methods for efficiently synthesizing these peptides from readily available compounds are disclosed.
Patent IE-54160-B1 (IE)
Title: Portable probe carrier
IPC: G01M15/04
Filed: 1983-03-04
Abstract: A portable case structure (30) functions as the depository, transporter and remote work site satellite for a plurality of engine sensor probes which communicate with a parent test console (10) through a common electrical umbilical connection (32).
Patent IE-38976-B1 (IE)
Title: Manufacture of curable polyester molding compositions
IPC: C08L67/00
Filed: 1974-03-07
Abstract: A process for the manufacture of curable unsaturated polyester molding compositions. To a mixture of A. AT LEAST ONE UNSATURATED POLYESTER, B. AT LEAST ONE COPOLYMERIZABLE OLEFINICALLY UNSATURATED COMPOUND, C. AN ALKALINE EARTH METAL OXIDE AND/OR HYDROXIDE, D. AT LEAST ONE INHIBITOR AND, OPTIONALLY, E. CONVENTIONAL FILLERS, REINFORCING AGENTS, INERT SOLVENTS, POLYMERIZATION ACCELERATORS AND/OR OTHER AUXILIARIES CONVENTIONALLY USED IN THE PROCESSING OF POLYESTER MOLDING COMPOSITIONS, THERE IS ADDED FROM 0.005 TO 1% BY WEIGHT, BASED ON UNSATURATED POLYESTER RESIN (A) PLUS (B), OR AT LEAST ONE COMPOUND OF THE GENERAL FORMULA Z On Xm WHERE Z denotes hydrogen, deuterium, phosphorus, boron, aluminum, gallium, silicon, germanium, tin, lead, antimony, bismuth, zinc, titanium, zirconium or sulfur and X denotes fluorine, chlorine, bromine, iodine or a mixture thereof and n denotes 0, 1 or 2 and m denotes 2, 3, 4, 5 or 6. The process of the invention is used for rapid thickening of molding compositions of unsaturated polyester resins.
[US3894984A]
Patent IE-52015-B1 (IE)
Title: 1-(acylamino-aryloxy)-3-alkynylamino-propan-2-ols,processes for their preparation and pharmaceutical compositions containing them
IPC: A61P9/00
Filed: 1981-03-06
Abstract: The invention relates to a compound of the formula wherein R1 is a linear or branched alkyl of 4 to 20 carbon atoms; R2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or a bivalent radical -CH=CH-CH=CH- or -(CH2)n-, where n is an integer from 3 to 5, inclusive, and the free bonds of said bivalent radical are attached to adjacent carbon atoms of the phenyl ring; and R3 is hydrogen or alkyl of 1 to 3 carbon atoms; R4 is alkyl of 1 to 3 carbon atoms; or R3 and R4, together with each other, are -(CH2)p-, where p is an integer from 4 to 6, inclusive, or a non-toxic, pharmacologically acceptable acid addition salt thereof. The compounds of formula I are useful for treatment and prophylaxis of diseases of the coronaries, for the treatment of hypertension, and for treatment of cardiac arrhythmia, particularly tachycardia.
Patent IE-32132-B1 (IE)
Title: A method of combating weeds with herbicides containing n-trifluoromethylphenyl-n',n-dimethylureas
IPC: A01N47/30
Filed: 1968-06-12
Abstract: 1,182,373. Herbicidal method using trifluoromethylphenyldimethylurea. CIBA Ltd. 12 June, 1968 [16 June, 1967], No. 27933/68. Heading A5E. A method of combatting weeds in sugarbeet cultures comprises applying to the cultures N-4-trifluoromethyl phenyl-N', N'-dimethylurea optionally together with a carrier. Specification 914,779 is referred to.
[GB1182373A]
Patent IE-61626-B1 (IE)
Title: Mycoplasma hyopneumoniae antigen and uses therefor
Inventor: BROOKS EMILY
IPC: C07K14/30
Filed: 1988-03-16
Abstract: A vaccine for M. hyopneumoniae is comprised of M. hyopneumoniae antigen(s), or fragments, which lack immunosuppressive activity.
Patent IE-32868-B1 (IE)
Title: Halogenated steroids and process for the manufacture thereof
IPC: A61K/
Filed: 1969-06-09
Abstract: 1,244,560. 4,7 - Dichlorosteroids. F. HOFFMANN-LA ROCHE & CO. A.G. 9 June, 1969 [8 Jan., 1969], No. 29012/69. Heading C2U. The invention comprises steroids of formula wherein R 1 is F, Cl, Br or C 1-8 alkyl; Q is oxo, OH, C 2-8 alkanoyloxy or C 2-4 1<SP>1</SP>,2<SP>1</SP>-alkylenedioxy; and M is a structure of formula wherein R 2 is H or F; R 3 is H, OH, C 1-8 alkoxy, C 2-8 alkanoyloxy, COCHF 2 , COCHCl 2 or C 1-8 alkyl; and R 4 is H, C 1-8 alkyl or C 1-8 alkylidene; or R 3 and R 4 together represent a 16α,17α- [1<SP>1</SP> - (C 1-8 alkyl) - C 1-8 alkylidenedioxy] group; X is a #<SP>1</SP> - unsaturation or a 2 - chloro or 1α,2α- methylene substituent; and n is 0 or 1; or M is a structure of formula wherein R 5 is H or C 2-8 alkanoyl; R 6 is H, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 2-8 haloalkenyl or C 2-8 haloalkynyl; R 7 is H or Me; X<SP>1</SP> is a #<SP>1</SP>-unsaturation or a 2-chloro substituent; n is 0 or 1; and Y is CH 2 , CH(#OH), CH(α-OH) or CO; with the proviso that when X<SP>1</SP> is a #<SP>1</SP> - unsaturation and n is 1, then R 7 is Me; or M is a structure of formula wherein R8 is H, F, Cl or Br; R 9 is H, OH, OPO(OH) 2 , an alkali metal salt of OPO(OH) 2 or C 2-8 alkanoyloxy; R 10 is H, α-OH, C 1-8 alkylidene, α-F, α-Cl, α-CH 2 Cl, α-CH 2 F or α- or #-C 1-8 alkyl; R 11 is OH or C 2-8 alkanoyloxy; or R 10 and R 11 together represent a 16α,17α- [1<SP>1</SP> - (C 1-8 alkyl) - C 1-8 alkylidenedioxy] group; or R 9 and R 11 together represent a 17α,21- [1<SP>1</SP> - (C 1-8 alkoxy) - C 1-8 alkylidenedioxy] group; X<SP>1</SP> is a #<SP>1</SP>-unsaturation or a 2-chloro substituent; n is 0 or 1; Z is CO, CH(α-OH), CH(#-OH), CH(α-OSO 2 R 12 ) where R 12 is C 1-8 alkyl or ptolyl, or when R 8 is H and R 9 is other than H, Z may be CH 2 , or when R 8 is Cl Z may be CH(#-CI), or Z and R 8 together represent a -CH = or -CH(α-epoxy) grouping. Preparation of the above compounds is by reaction of chlorine with compounds of formula (wherein M<SP>1</SP> is as defined above for M except that no #<SP>1</SP>-unsaturation may be present) followed when required by conventional conversions of the 3-oxo group into other values of Q defined above and/or by 1,2-dehydrogenation. The inventive compounds are stated to possess progestational, cortieoid, antiinflammatory and thymolytio activities, and may be made up with carriers into pharmaceutical compositions for oral, parenteral and rectal administration.
[GB1244560A]
Patent IE-59405-B1 (IE)
Title: Defect detector for cord reinforced tyre fabric
IPC: G01N23/18
Filed: 1986-04-10
Abstract: A system for detecting missing or crossed cords in cord reinforced tyre fabric. The entire width of the fabric as it is being made is scanned by a highly collimated X-ray source and a sensor. A change in the amount of X-ray radiation penetrating the fabric indicates the presence of the cords. A counter which counts at a fixed rate is gated on during the time that a cord's presence is detected. The total count in a small section of the fabric, called a slice, is proportional to the number of strands in the slice. Since the counting rate is relatively high with respect to the scan time, the system can easily detect missing or overlapping cords.